Regulatory News
Wednesday, February 1, 2017
BRIEF-Audentes Therapeutics announces FDA clearance of investigational new drug application for AT342
* Audentes Therapeutics announces FDA clearance of
investigational new drug application for AT342 to treat
Crigler-Najjar Syndrome
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment